PeptiDream
PeptiDream Inc is a Japanese biopharmaceutical company focused on discovering and developing constrained peptide therapeutics and peptide-drug conjugates. The company utilizes its proprietary Peptide Discovery Platform System to design non-standard peptide therapeutics, radiopharmaceutical conjugates, and targeted delivery vehicles. Revenue is primarily generated through research collaboration upfront payments, development milestone fees, technology licensing, and commercial royalty sharing with global pharmaceutical partners. Core end markets encompass global biopharmaceutical corporations, clinical research organizations, and specialized oncology centers. PeptiDream holds a market-leading position in Japan and globally as a foundational technology provider for non-standard peptide drug discovery. The company is headquartered in Kawasaki, Japan, and its common stock trades on the Tokyo Stock Exchange.
6 of the funds FundTelligence covers report a position in PeptiDream.
- Legal name
- PeptiDream Inc
- Sector
- Health Care
- Country
- Japan
- Funds holding it
- 6
Funds holding PeptiDream
- Schroder ISF Japanese Opportunities — Schroders · 0.71 % (full portfolio disclosed, June 2026)
- Nordea BetaPlus Enhanced Global Sustainable Small Cap — Nordea Funds · 0.14 % (full portfolio disclosed, September 2026)
- Handelsbanken Global SMB Index Criteria — Handelsbanken · 0.02 % (full portfolio disclosed, October 2026)
- DNB Global Enhanced Small Cap — DNB · 0.01 % (full portfolio disclosed, September 2026)
- Nordea Internationale aktier — Nordea Funds · 0.01 % (full portfolio disclosed, September 2026)
- KLP AksjeGlobal Small Cap Indeks — KLP · 0.01 % (partially disclosed portfolio, June 2026)